Nautilus Biotechnology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nautilus Biotechnology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q3 2024.
  • Nautilus Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$16.4M, a 3.58% decline year-over-year.
  • Nautilus Biotechnology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$70.2M, a 16.9% decline year-over-year.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$63.7M, a 9.93% decline from 2022.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$57.9M, a 15.1% decline from 2021.
  • Nautilus Biotechnology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$50.3M, a 222% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$70.2M -$16.4M -$568K -3.58% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$69.6M -$18M -$2.2M -13.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 -$67.4M -$18.7M -$3.77M -25.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 -$63.7M -$17M -$3.62M -27% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$60.1M -$15.9M -$1.82M -12.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$58.2M -$15.8M -$1.12M -7.62% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 -$57.1M -$15M +$798K +5.06% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 -$57.9M -$13.4M +$3.28M +19.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$61.2M -$14.1M +$441K +3.04% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 -$61.6M -$14.7M -$3.98M -37.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$57.7M -$15.8M -$7.35M -87.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$50.3M -$16.7M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$14.5M -$10.5M -265% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$10.7M -$7.36M -219% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$8.41M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q3 2020 -$3.98M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$3.36M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.